Programme
ABC7 - Final Programme
Available HERE
All pre-recorded lectures will be available on-demand on the event platform: cAttendee (abstractsonline.com)
THURSDAY, 9 NOVEMBER 2023 |
||
9:00-10:30 |
Patient advocacy session: Beyond my cancer treatments: What else? |
Chairs: Maria Joao Cardoso, PT and Renate Haidinger, DE |
- Over the counter in advanced breast cancer. Fears and questions? |
Maria Joao Cardoso, PT and Renate Haidinger, DE |
|
- Integrative Medicine in Advanced Breast Cancer Treatment. The Actual Panorama and how it can be improved. |
Rachel Würstlein, DE |
|
- The medical oncologist needs. How to deal with no information |
Silvia Neciosup, PE |
|
- What else besides the cancer medication. What is good and what is bad. The interactions |
Andre Dourado, ES |
|
- Discussion |
All |
|
10:30-11:00 |
Coffee break |
|
11:00-12:30 |
Patient advocacy session: Complexities of shared decision making |
Chairs: Elizabeth Bergsten Nordstrom, SE, Ginny Mason, US and Eva Schumacher-Wulf, DE |
- Introduction |
Elizabeth Bergsten Nordstrom, SE and Ginny Mason, US |
|
- How mental health issues influence shared decision-making |
Lesley Fallowfield, UK |
|
- How to discuss survival times and be prepared for end-of-life care decisions |
Belinda Kiely, AU |
|
- Overcoming my fears and being prepared |
Claire Myerson, UK |
|
- Discussion |
All |
|
11:00-12:30 |
Sponsored Lecture |
|
12:30-13:30 |
Lunch |
|
13:30-15:10
|
Opening session |
Chairs: Fatima Cardoso, PT and Larry Norton, US |
- Opening - Welcome to Lisbon |
Carlos Moedas, Mayor of Lisbon, PT |
|
- Welcome message European Commissioner for Health and Food Safety |
Stella Kyriakides, BE |
|
- Welcome to ABC7 |
Fatima Cardoso, PT |
|
- From daughter to decision maker: The shifting role of a caregiver in metastatic breast cancer |
Sarah-Jane Barker, UK |
|
- ABC7 Award lecture: The Spark that Lit the Fire - My journeys with ABC patients and their families |
Lillie Shockney, US |
|
15:10-15:50 |
Best Abstract Presentation |
Chairs: Eric P. Winer, US and Eva Schumacher-Wulf, DE |
- Updated overall survival (OS) outcomes from the phase 3 PHOEBE trial of pyrotinib plus capecitabine versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer | Xichun Hu, CN | |
- Enhancing patient care: interim data analysis and patient experience of personalized electronic symptom monitoring led by a specialist nurse for engagement in treatment and improved quality of life in advanced breast cancer | Marion Kuper-Hommel, NZ | |
- The impact on productivity costs of reducing unemployment in patients with advanced breast cancer: A model estimation based on a Portuguese nationwide observational study | Leonor Matos, PT | |
- Discussion | All | |
15:50-16:20 |
Coffee break |
|
16:20-18:00 |
Clinical Dilemmas |
Chairs: Claire Myerson, UK and Sandra Swain, US |
- Impact of new early breast cancer standards in the choice of first line therapies |
Mariana Chavez MacGregor, US |
|
- How to optimize care for long term responders: to be or not to be on "treatment holidays" |
Joseph Gligorov, FR |
|
- From DNR to ICU - expanding the rights of ABC patients |
Ann H. Partridge, US |
|
- New QoL tools for ABC: EU H2O project and EORTC / ABC Global Alliance tool
|
Galina Velikova, UK
|
|
|
- Discussion |
All |
18:00-19:30 |
Patient advocacy session: The central role of nursing for ABC patients |
Chairs: Andrea Smith, AU and Theresa Wiseman, UK |
- Welcome |
||
- What difference can nurses make to the care of patients with ABC? The perspective of patients and family members |
Andrea Smith, AU |
|
- The specialised metastatic breast care nurse role in Australia. The nurses’ role in helping people manage side effects, treatment and emergencies |
Jenny Gilchrist, AU |
|
- Nursing support for ABC patients: perspective from low and middle-income countries |
Nanre Mampak, NG |
|
- Enabling nurses to provide appropriate care for patients with ABC: the development of a specialised training program for ABC nurses |
Amanda Drury, IE |
|
- Discussion |
Amanda Drury, IE - Vicky Durston, AU - Jenny Gilchrist, AU - Nanre Mampak, NG - Andrea Smith, AU and Theresa Wiseman, UK |
|
18:00-19:30 |
Sponsored Lecture |
|
19:30 |
Welcome cocktail |
FRIDAY, 10 NOVEMBER 2023 |
||
08:30-09:30 |
Biology 1.0 |
Chairs: Mariana Chavez MacGregor, US and Alex Eniu, CH |
- Interpreting a NGS report |
Nadia Harbeck, DE |
|
- Interpreting a liquid biopsy report |
Nick Turner, UK |
|
- Interpreting a genetic test report |
Shani Paluch-Shimon, IL |
|
|
- Discussion |
All |
9:30-10:45 |
Biology 2.0 |
Chairs: Belinda Kiely, AU and Sung-Bae Kim, KR |
- Optimizing molecular subtypes classification |
William J. Gradishar, US |
|
- How low should we go? HER2 low, ER low |
Frédérique Penault-Llorca, FR |
|
- Redefining endocrine resistance |
Lisa Carey, US |
|
- How can Artificial Intelligence help? |
Dimitris Kalogeropoulos, UK |
|
- Discussion |
All |
|
10:45-11:15 |
Coffee break |
|
11:15-12:15 |
Loco-regional highlights |
Chairs: Marion Kuper-Hommel, NZ and Elzbieta Senkus, PL |
- When should the primary tumor be treated in ABC? |
Maria João Cardoso, PT
|
|
- Leveraging concomitant radio-targeted therapy for MBC and inoperable LABC |
Brigitte V. Offersen, DK |
|
- Revisiting oligometastatic disease |
Prue Francis, AU |
|
|
- Discussion |
All |
12:15-13:00 |
Improving Imaging of ABC |
Chairs: William J. Gradishar, US |
- Optimal use of Pet-CT in ABC: new EANM-SNMMI guidelines |
Lioe-Fee de Geus, NL |
|
- New Imaging technologies for ABC |
Frédéric E. Lecouvet, BE |
|
- Discussion |
All |
|
13:00-14:00 |
Poster Session |
|
13:00-14:00 |
Lunch |
|
14:00-15:30 |
Tough issues in ABC. Report from WebSeries |
Chairs: Matti S. Aapro, CH and Gertrude Nakigudde, UG |
- ABC in a pregnant patient |
Matteo Lambertini, IT | |
- Optimal management of inflammatory inoperable LABC and/or MBC |
Karen Gelmon, CA
|
|
- Optimal management of a patient with ABC in visceral crisis |
Hope S. Rugo, US
|
|
- Management a patient with ABC and HIV |
Peter Vuylsteke, BW |
|
- Optimal management of an older frail patient with ABC |
Laura Biganzoli, IT |
|
- Management of leptomeningeal disease |
Volkmar Mueller, DE |
|
15:30-15:50 |
Coffee break |
|
|
|
|
15:50-17:05 |
The perfect storm: war, recession, regulatory/payers hurdles |
Chairs: Nagi S. El Saghir, LB and Carlos H. Barrios, BR and Marzia Zambon, IT |
- Caring for cancer patients amidst war |
Richard Sullivan, UK |
|
- Barriers and inequalities due to old fashion regulatory and / or recruitment rules |
Bishal Gyawali, CA |
|
- Will the WHO Global Breast Cancer Initiative (GBCI) help ABC patients? |
Andre Ilbawi, CH
|
|
- The new Lancet Commission on BC: a powerful lobbying for ABC |
Charlotte Coles, UK |
|
- Discussion |
All |
|
17:05-18:00 |
News from ABC6 |
Chairs: Silvia Neciosup, PE and Shinji Ohno, JP |
- HER2+ |
Javier Cortes, ES |
|
- ER+ / Her2 Neg |
Sandra Franco, CO |
|
- Triple negative |
Rebecca A. Dent, SG |
|
|
- Discussion |
All |
18:00-19:30 |
Patient advocacy session: Rehabilitation to manage disabilities in metastatic breast cancer |
Chairs: Runcie Chidebe, NG and Ranjit Kaur, MY |
- Introduction |
Runcie Chidebe, NG and Ranjit Kaur, MY |
|
- My multiple burdens of living with MBC, disabilities, poor access to care and workplace issues. |
Shirley Mertz, US |
|
- Relationship between diet and exercise in MBC patients |
Leonor Matos, PT |
|
- Managing Lymphoedema in MBC patients |
Isabelle Aloi-Timeus, MX |
|
- Discussion |
All |
|
18:00-19:30 |
Sponsored Lecture |
|
SATURDAY, 11 NOVEMBER 2023 |
||
8:30-10:30 |
Consensus session (part I) |
ABC7 Chairs, Scientific Committee Members and Panellists |
10:30-11:00 |
Coffee break |
|
11:00-11:15 |
Report from ABC Patient Advocacy Committee |
Isabelle Aloi-Timeus, MX |
11:15-12:45 |
Consensus session (part II) |
ABC7 Chairs, Scientific Committee Members and Panellists |
12:45-13:00 |
Close |
|
SPONSORED SATELLITE SYMPOSIA
Daiichi Sankyo | AstraZeneca sponsored satellite symposium: Connecting the dots with ADCs: Integrating patient experiences and recent data in metastatic breast cancer
>> Not available on demand
Stemline. A Menarini Group sponsored satellite symposium: Current and upcoming treatment strategies after CDK4/6 inhibitors for patients with ER+/HER2- advanced breast cancer
>> Available on demand